Jörg Daumann

3.1k total citations
55 papers, 2.2k citations indexed

About

Jörg Daumann is a scholar working on Clinical Psychology, Cellular and Molecular Neuroscience and Toxicology. According to data from OpenAlex, Jörg Daumann has authored 55 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Clinical Psychology, 26 papers in Cellular and Molecular Neuroscience and 25 papers in Toxicology. Recurrent topics in Jörg Daumann's work include Neurotransmitter Receptor Influence on Behavior (25 papers), Forensic Toxicology and Drug Analysis (25 papers) and Cannabis and Cannabinoid Research (20 papers). Jörg Daumann is often cited by papers focused on Neurotransmitter Receptor Influence on Behavior (25 papers), Forensic Toxicology and Drug Analysis (25 papers) and Cannabis and Cannabinoid Research (20 papers). Jörg Daumann collaborates with scholars based in Germany, United States and Switzerland. Jörg Daumann's co-authors include Euphrosyne Gouzoulis‐Mayfrank, Karsten Heekeren, Daniel Wagner, Benjamin Becker, A. Thron, Thomas Schnell, Anna Neukirch, Knut Schnell, Jens Kuhn and Doris Lenartz and has published in prestigious journals such as NeuroImage, Brain and Biological Psychiatry.

In The Last Decade

Jörg Daumann

55 papers receiving 2.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jörg Daumann Germany 30 911 894 816 756 555 55 2.2k
Paul D. Morrison United Kingdom 24 1.4k 1.5× 439 0.5× 2.4k 2.9× 266 0.4× 729 1.3× 40 3.4k
Robert Hitzemann United States 7 1.5k 1.7× 173 0.2× 265 0.3× 300 0.4× 493 0.9× 8 2.0k
Matthijs G. Bossong Netherlands 31 1.3k 1.4× 379 0.4× 1.8k 2.2× 202 0.3× 903 1.6× 71 3.3k
Joshua A. Lile United States 28 1.3k 1.4× 256 0.3× 645 0.8× 260 0.3× 426 0.8× 102 2.0k
G.-J. Wang United States 13 1.7k 1.9× 273 0.3× 276 0.3× 132 0.2× 975 1.8× 15 3.1k
Patrick D. Skosnik United States 31 1.0k 1.1× 376 0.4× 1.1k 1.4× 90 0.1× 793 1.4× 63 2.5k
Linda D. Simmler Switzerland 22 1.3k 1.4× 1.4k 1.6× 500 0.6× 1.2k 1.6× 192 0.3× 34 2.3k
Allegra Broft United States 19 1.5k 1.6× 461 0.5× 309 0.4× 66 0.1× 916 1.7× 25 2.5k
Ruth Salo United States 23 924 1.0× 258 0.3× 167 0.2× 208 0.3× 876 1.6× 34 1.9k
Emanuela Mundo Italy 35 961 1.1× 1.4k 1.6× 416 0.5× 87 0.1× 736 1.3× 67 3.7k

Countries citing papers authored by Jörg Daumann

Since Specialization
Citations

This map shows the geographic impact of Jörg Daumann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jörg Daumann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jörg Daumann more than expected).

Fields of papers citing papers by Jörg Daumann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jörg Daumann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jörg Daumann. The network helps show where Jörg Daumann may publish in the future.

Co-authorship network of co-authors of Jörg Daumann

This figure shows the co-authorship network connecting the top 25 collaborators of Jörg Daumann. A scholar is included among the top collaborators of Jörg Daumann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jörg Daumann. Jörg Daumann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kendrick, Keith M., Jörg Daumann, Daniel Wagner, et al.. (2021). A prospective longitudinal study shows putamen volume is associated with moderate amphetamine use and resultant cognitive impairments. PubMed. 1(1). 3–12. 4 indexed citations
2.
Schnell, Thomas, Karsten Heekeren, Jörg Daumann, & Euphrosyne Gouzoulis‐Mayfrank. (2018). Inhibition of return (IOR) in patients with schizophrenia and cannabis use. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 89. 65–72. 3 indexed citations
3.
Daumann, Jörg & Euphrosyne Gouzoulis‐Mayfrank. (2015). Amphetamine, Ecstasy und Designerdrogen. 3 indexed citations
4.
Becker, Benjamin, Daniel Wagner, Marc Tittgemeyer, et al.. (2015). Smaller amygdala and medial prefrontal cortex predict escalating stimulant use. Brain. 138(7). 2074–2086. 47 indexed citations
5.
Gouzoulis‐Mayfrank, Euphrosyne, et al.. (2015). Trans-Sector Integrated Treatment in Psychosis and Addiction. Deutsches Ärzteblatt international. 112(41). 683–91. 16 indexed citations
6.
Wagner, Daniel, et al.. (2015). Learning, Memory, and Executive Function in New MDMA Users: A 2-Year Follow-Up Study. Frontiers in Neuroscience. 9. 445–445. 11 indexed citations
7.
Wagner, Daniel, et al.. (2014). Interactions between specific parameters of MDMA use and cognitive and psychopathological measures. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 58. 32–37. 1 indexed citations
8.
Huys, Daniel, Christina Bartsch, Doris Lenartz, et al.. (2014). Motor Improvement and Emotional Stabilization in Patients With Tourette Syndrome After Deep Brain Stimulation of the Ventral Anterior and Ventrolateral Motor Part of the Thalamus. Biological Psychiatry. 79(5). 392–401. 53 indexed citations
9.
Kuhn, Jens, Christina Bartsch, Doris Lenartz, et al.. (2011). Clinical effectiveness of unilateral deep brain stimulation in Tourette syndrome. Translational Psychiatry. 1(11). e52–e52. 18 indexed citations
10.
Becker, Benjamin, Daniel Wagner, Euphrosyne Gouzoulis‐Mayfrank, Elmar Spuentrup, & Jörg Daumann. (2010). The impact of early-onset cannabis use on functional brain correlates of working memory. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 34(6). 837–845. 77 indexed citations
11.
Schnell, Thomas, Dagmar Koethe, Jörg Daumann, & Euphrosyne Gouzoulis‐Mayfrank. (2009). The role of cannabis in cognitive functioning of patients with schizophrenia. Psychopharmacology. 205(1). 45–52. 75 indexed citations
12.
Huff, W., Doris Lenartz, Sunhee Lee, et al.. (2009). Unilateral deep brain stimulation of the nucleus accumbens in patients with treatment-resistant obsessive-compulsive disorder: Outcomes after one year. Clinical Neurology and Neurosurgery. 112(2). 137–143. 217 indexed citations
13.
Gouzoulis‐Mayfrank, Euphrosyne, Maryam Balke, Stephan Ruhrmann, et al.. (2007). Orienting of attention in unmedicated patients with schizophrenia, prodromal subjects and healthy relatives. Schizophrenia Research. 97(1-3). 35–42. 27 indexed citations
14.
Parrott, A. C., Raffaella Margherita Milani, Euphrosyne Gouzoulis‐Mayfrank, & Jörg Daumann. (2007). Cannabis and Ecstasy/MDMA (3,4-methylenedioxymethamphetamine): an analysis of their neuropsychobiological interactions in recreational users. Journal of Neural Transmission. 114(8). 959–968. 54 indexed citations
15.
16.
Schnell, Knut, Thomas Dietrich, Ralph Schnitker, Jörg Daumann, & Sabine C. Herpertz. (2006). Processing of autobiographical memory retrieval cues in borderline personality disorder. Journal of Affective Disorders. 97(1-3). 253–259. 49 indexed citations
17.
Gouzoulis‐Mayfrank, Euphrosyne, et al.. (2005). Inhibition of Return in the Human 5HT2A Agonist and NMDA Antagonist Model of Psychosis. Neuropsychopharmacology. 31(2). 431–441. 36 indexed citations
18.
Daumann, Jörg, et al.. (2004). Proton magnetic resonance spectroscopy in ecstasy (MDMA) users. Neuroscience Letters. 362(2). 113–116. 29 indexed citations
19.
Daumann, Jörg, Ralph Schnitker, Jürgen Weidemann, et al.. (2003). Neural correlates of working memory in pure and polyvalent ecstasy (MDMA) users. Neuroreport. 14(15). 1983–1987. 37 indexed citations
20.
Gouzoulis‐Mayfrank, Euphrosyne, Jörg Daumann, & Henning Saß. (2002). Neurotoxische Langzeitschäden bei Ecstasy (MDMA)-KonsumentenÜberblick über den aktuellen Wissensstand. Der Nervenarzt. 73(5). 405–421. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026